SlateStone Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.93M Sell
62,995
-3,426
-5% -$276K 0.38% 67
2026
Q1
$5.75M Buy
66,421
+3,689
+6% +$353K 0.47% 61
2025
Q4
$6.03M Buy
62,732
+892
+1% +$86.6K 0.5% 57
2025
Q3
$5.89M Buy
61,840
+2,556
+4% +$235K 0.51% 57
2025
Q2
$5.17M Buy
59,284
+3,442
+6% +$292K 0.48% 62
2025
Q1
$5.02M Buy
55,842
+833
+2% +$74.5K 0.5% 58
2024
Q4
$4.39M Buy
55,009
+829
+2% +$71.8K 0.43% 66
2024
Q3
$4.88M Buy
54,180
+22,690
+72% +$1.91M 0.44% 63
2024
Q2
$2.48M Sell
31,490
-17,402
-36% -$1.43M 0.27% 83
2024
Q1
$4.26M Buy
48,892
+32,778
+203% +$2.8M 0.43% 69
2023
Q4
$1.33M Sell
16,114
-1,076
-6% -$82K 0.17% 106
2023
Q3
$1.35M Buy
17,190
+13,458
+361% +$1.13M 0.2% 100
2023
Q2
$329K Sell
3,732
-1,750
-32% -$151K 0.06% 172
2023
Q1
$442K Sell
5,482
-210
-4% -$17.1K 0.09% 150
2022
Q4
$442K Sell
5,692
-950
-14% -$77K 0.11% 125
2022
Q3
$536K Buy
6,642
+200
+3% +$18K 0.14% 107
2022
Q2
$578K Buy
6,442
+320
+5% +$32.4K 0.15% 102
2022
Q1
$679K Buy
6,122
+160
+3% +$16.9K 0.15% 97
2021
Q4
$617K Hold
5,962
0.13% 108
2021
Q3
$747K Buy
+5,962
New +$772K 0.17% 98
2020
Q4
Sell
-2,100
Closed -$219K 178
2020
Q3
$219K Buy
+2,100
New +$211K 0.05% 165
2020
Q2
Sell
-5,196
Closed -$469K 186
2020
Q1
$469K Buy
5,196
+110
+2% +$11.7K 0.13% 120
2019
Q4
$577K Buy
+5,086
New +$558K 0.13% 119

Other funds holding MDT

SlateStone Wealth's MDT Position: Q2 2026 in Review

SlateStone Wealth reduced its Medtronic (MDT) stake by 5.2% in Q2 2026, selling an estimated $276K and leaving 62,995 shares worth $4.93M. The position accounts for 0.38% of the portfolio, ranked #67.

SlateStone Wealth first reported a position in MDT in Q4 2019 and has held it in 23 quarters since. The position peaked at $6.03M in Q4 2025. 576 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • SlateStone Wealth held 62,995 shares of Medtronic worth $4.93M as of Q2 2026.
  • SlateStone Wealth sold 3,426 Medtronic shares in Q2 2026, an estimated $276K.
  • Medtronic made up 0.38% of SlateStone Wealth's portfolio in Q2 2026, its #67 holding.
  • SlateStone Wealth first reported a position in Medtronic in Q4 2019 and has held it in 23 quarters since.
  • SlateStone Wealth's Medtronic position peaked at $6.03M in Q4 2025.
  • 576 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on SlateStone Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.